Kanamycin Injection
» Kanamycin Injection contains an amount of Kanamycin Sulfate equivalent to not less than 90.0 percent and not more than 115.0 percent of the labeled amount of kanamycin (C18H36N4O11). It contains suitable buffers and preservatives.
Packaging and storage— Preserve in single-dose or in multiple-dose containers, preferably of Type I or Type III glass.
Identification—
A: Dilute a suitable volume of Injection with water to obtain a test solution having a concentration of about 1 mg of kanamycin per mL. This solution meets the requirements of Identification test A under Kanamycin Sulfate Capsules.
B: The retention time of the peak for kanamycin in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Bacterial endotoxins 85 It contains not more than 0.67 USP Endotoxin Unit per mg of kanamycin.
Sterility 71 It meets the requirements when tested as directed for Membrane Filtration under Test for Sterility of the Product to be Examined.
pH 791: between 3.5 and 5.0.
Particulate matter 788: meets the requirements for small-volume injections.
Other requirements— It meets the requirements under Injections 1.
Assay—
Mobile phase, Resolution solution, Standard preparation, and Chromatographic system Proceed as directed in the Assay under Kanamycin Sulfate.
Assay preparation— Dilute an accurately measured volume of Injection quantitatively, and stepwise if necessary, with water to obtain a solution having a concentration of about 0.006 mg of kanamycin per mL.
Procedure— Proceed as directed in the Assay under Kanamycin Sulfate. Calculate the quantity, in mg, of kanamycin (C18H36N4O11) in each mL of the Injection taken by the formula:
(L / D)(CP / 1000)(rU / rS)
in which L is the labeled quantity, in mg, of kanamycin in each mL of the Injection; D is the concentration, in mg per mL, of kanamycin in the Assay preparation, on the basis of the labeled quantity per mL and the extent of dilution; and the other terms are as defined therein.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Ahalya Wise, M.S.
Scientist
1-301-816-8161
(MDANT05) Monograph Development-Antibiotics
Reference Standards Lili Wang, Technical Services Scientist
1-301-816-8129
RSTech@usp.org
85 Radhakrishna S Tirumalai, Ph.D.
Senior Scientist
1-301-816-8339
(MSA05) Microbiology and Sterility Assurance
71 Radhakrishna S Tirumalai, Ph.D.
Senior Scientist
1-301-816-8339
(MSA05) Microbiology and Sterility Assurance
USP32–NF27 Page 2735
Pharmacopeial Forum: Volume No. 26(6) Page 1554
Chromatographic Column—
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.